In Vitro Generation of a Scaffold-Free Tissue-Engineered Construct (TEC) Derived from Human Synovial Mesenchymal Stem Cells: Biological and Mechanical Properties and Further Chondrogenic Potential
Abstract:The purpose of this study was to characterize a tissue-engineered construct (TEC) generated with human synovial mesenchymal stem cells (MSCs). MSCs were cultured in medium with ascorbic acid 2-phosphate (Asc-2P) and were subsequently detached from the substratum. The detached cell/matrix complex spontaneously contracted to develop a basic TEC. The volume of the TEC assessed by varying initial cell density showed that it was proportional to initial cell densities up to 4 x 10(5) cells/cm(2). Assessment of the m… Show more
“…This group demonstrated cells' ability to adhere to human chondral fragments [56], as it was previously demonstrated in the pig model. They also applied a xeno-free technique, by using human serum [5,56].…”
“…This group demonstrated cells' ability to adhere to human chondral fragments [56], as it was previously demonstrated in the pig model. They also applied a xeno-free technique, by using human serum [5,56]. Autologous human serum is reported to be more effective in promoting SM-MSCs' proliferation, in comparison to other MSC sources [5,10,57].…”
“…Scaffoldfree tissue-engineered constructs (TECs) were developed in order to overcome the previous drawbacks. MSCs are cultured in monolayer with addition of ascorbic acid and are then submitted to shear stress, resulting in their detachment and spontaneous contraction to form the 3D structure, similar to what is observed with collagen gels [56].…”
“…The TEC showed to have stable adhesion to a porcine cartilage matrix, in an explant culture, possibly due to the adhesion properties of fibronectin. When cultured in chondrogenic medium, enhanced expression of glycosaminoglycans and chondrogenic matrix genes, as collagen II and aggrecan, was observed [33,56], suggesting that SM-MSCs in the TEC retain their chondrogenic potential [56]. They also proposed a xenofree system for the development of this technique, as the TEC is produced without an exogenous scaffold, with autologous serum and MSCs.…”
Musculoskeletal injuries impact millions of people globally and affect their health and well-being as well as of their companion and athletic animals. Soft-tissue injuries represent almost half of these and are associated with unorganized scar tissue formation and long time-depending healing processes. Cell-based therapeutic strategies have been developed in the past decades aiming at the treatment and reversion of such disorders. Stem cells are fairly appealing in the field, being a responsive undifferentiated population, with ability to self-renew and differentiate into different lineages. Mesenchymal stem cells (MSCs) can be obtained from several adult tissues, including the synovial membrane. Synovia-derived MSCs can be found in individuals of any age and are associated to intrinsic regenerative processes, through both paracrine and cell-to-cell interactions, thus, contributing to hosts' healing capacity. Studies have demonstrated the potential benefit of synovia-derived MSCs in these regenerative processes in both human and veterinary medicine. The purpose of this chapter is to review the literature regarding SM-MSC therapies applied to musculoskeletal disorders, in both human and veterinary medicine.
“…This group demonstrated cells' ability to adhere to human chondral fragments [56], as it was previously demonstrated in the pig model. They also applied a xeno-free technique, by using human serum [5,56].…”
“…This group demonstrated cells' ability to adhere to human chondral fragments [56], as it was previously demonstrated in the pig model. They also applied a xeno-free technique, by using human serum [5,56]. Autologous human serum is reported to be more effective in promoting SM-MSCs' proliferation, in comparison to other MSC sources [5,10,57].…”
“…Scaffoldfree tissue-engineered constructs (TECs) were developed in order to overcome the previous drawbacks. MSCs are cultured in monolayer with addition of ascorbic acid and are then submitted to shear stress, resulting in their detachment and spontaneous contraction to form the 3D structure, similar to what is observed with collagen gels [56].…”
“…The TEC showed to have stable adhesion to a porcine cartilage matrix, in an explant culture, possibly due to the adhesion properties of fibronectin. When cultured in chondrogenic medium, enhanced expression of glycosaminoglycans and chondrogenic matrix genes, as collagen II and aggrecan, was observed [33,56], suggesting that SM-MSCs in the TEC retain their chondrogenic potential [56]. They also proposed a xenofree system for the development of this technique, as the TEC is produced without an exogenous scaffold, with autologous serum and MSCs.…”
Musculoskeletal injuries impact millions of people globally and affect their health and well-being as well as of their companion and athletic animals. Soft-tissue injuries represent almost half of these and are associated with unorganized scar tissue formation and long time-depending healing processes. Cell-based therapeutic strategies have been developed in the past decades aiming at the treatment and reversion of such disorders. Stem cells are fairly appealing in the field, being a responsive undifferentiated population, with ability to self-renew and differentiate into different lineages. Mesenchymal stem cells (MSCs) can be obtained from several adult tissues, including the synovial membrane. Synovia-derived MSCs can be found in individuals of any age and are associated to intrinsic regenerative processes, through both paracrine and cell-to-cell interactions, thus, contributing to hosts' healing capacity. Studies have demonstrated the potential benefit of synovia-derived MSCs in these regenerative processes in both human and veterinary medicine. The purpose of this chapter is to review the literature regarding SM-MSC therapies applied to musculoskeletal disorders, in both human and veterinary medicine.
“…Scaffolds may further be defined as ''smart scaffolds'' if they carry with them some type of signal that can direct appropriate tissue formation either from the implanted cell type or from the surrounding resident cellular population. With respect to the delivery of synoviocytes for cartilage (hyaline or fibrocartilage) engineering, a number of different systems have been investigated including hydrogels (alginate [53,66] collagen [51,63,94], and gellan [28]), pellet cultures [63,80], micromasses [3,66], small intestinal submucosa (SIS) [84], hyaluronan-based scaffolds (Hyaff-111; FAB, Abano Terme, Padova, Italy) [56], polyglycolic acid (PGA) [67,74], PGA/poly (L) lactic acid (PLLA) combinations [34], and scaffold-free cell infusions [44,60]. With relatively few studies directly comparing delivery methods, elucidating an optimal carrier or scaffold from the literature alone is difficult.…”
Mesenchymal stem cells (MSCs) represent a promising cell source to regenerate injured cartilage. In this study, MSCs are cultured under confluent condition for 10 days to optimize the deposition of extracellular matrix (mECM), which would serve as the scaffold to support MSC chondrogenesis. Subsequently, the MSC-impregnated mECM (MSC-mECM) composite is briefly treated with trypsin, allowing the MSCs to adopt a round morphology without being detached from their own mECM. The constructs are then culture in chondrogenic medium. Interestingly, after trypsin removal, the treated MSCs undergo an aggregation process, mimicking mesenchymal condensation during developmental chondrogenesis, specifically indicated by peanut agglutinin staining and immunodetectable N-cadherin expression, followed by robust chondrogenic differentiation. In comparison to conventional pellet culture, chondrogenically induced MSC-mECM displays similar level of chondrogenesis, but with significantly reduced hypertrophy. The reparative capacity of the MSC-mECM derived construct is assessed using bovine cartilage explants. Mechanical testing and histology results show that engineered cartilage from MSC-mECM forms better integration with surrounding native cartilage tissue and displays much lower hypertrophic differentiation than that from pellet culture. Taken together, these findings demonstrate that MSC-mECM may be an efficacious stem cell-based product for the repair of hyaline cartilage injury without the use of exogenous scaffolds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.